2004
DOI: 10.1128/jcm.42.11.4980-4987.2004
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study

Abstract: The PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin in the United States) surveillance program was established to determine the prevalence and mechanisms of antibacterial resistance among bacterial pathogens from patients with community-acquired respiratory tract infections. In year 1 of the PROTEKT US study, 10,103 isolates of Streptococcus pneumoniae, including 3,133 erythromycin-resistant strains and 81 levofloxacin-resistant strains, were collected from 2… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
20
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(22 citation statements)
references
References 35 publications
(39 reference statements)
2
20
0
Order By: Relevance
“…We presume that the high-level levofloxacin resistance of isolates with parE-only mutations was associated with efflux pump mechanisms (see below). The numerous QRDR mutations may not have any major effect on the fluoroquinolone MICs, as noted in a previous report (3). It is considered that for S. pneumoniae, ciprofloxacin is the drug most susceptible to efflux mechanisms (2,7,13,21).…”
Section: Distribution Of Macrolide Resistance Genes and Qrdr Mutationmentioning
confidence: 76%
“…We presume that the high-level levofloxacin resistance of isolates with parE-only mutations was associated with efflux pump mechanisms (see below). The numerous QRDR mutations may not have any major effect on the fluoroquinolone MICs, as noted in a previous report (3). It is considered that for S. pneumoniae, ciprofloxacin is the drug most susceptible to efflux mechanisms (2,7,13,21).…”
Section: Distribution Of Macrolide Resistance Genes and Qrdr Mutationmentioning
confidence: 76%
“…The current prevention strategies based on immunogenic properties of capsular polysaccharides rely on a 23-valent and a 7-valent conjugate vaccine, even though the latter does not offer complete serotype coverage (3,10,26). Pneumococcal infection treatments are impaired by the increased number of clinical strains resistant to single or multiple antibiotherapies (11,39). There is a pressing need for the development of a vaccine with a wider serotype coverage spectrum as well as for the development of new drugs.…”
mentioning
confidence: 99%
“…Antibiotic treatment of these infections has become increasingly problematic due to an emergence of resistance to both penicillin and non-␤-lactam antibiotics. During the last decade, a rapid increase in the resistance of S. pneumoniae to macrolides has been observed in the United States (3,12,13,19,43).…”
mentioning
confidence: 99%